PTAC/CFTR
John Lueck
Pharmacology and Physiology
University of Rochester Medical Center
Kathryn Oliver
Pediatrics
Emory University School of Medicine
Kim Keeling, PhD
University of Alabama at Birmingham
This session features a moderated discussion of emerging strategies developed to overcome CFTR premature termination codons (PTCs) and other rare variants unresponsive to clinically approved modulator therapies.
Speaker: Andrew Berical, MD (he/him/his) – Boston University School of Medicine
Speaker: Eric Wong, MS – Cystic Fibrosis Foundation
Speaker: Ashley Cooney, PhD – University of Iowa
Speaker: Joseph J. Porter, PhD – University of Rochester Medical Center
Speaker: Kari D. Thrasher – University of Alabama at Birmingham
Speaker: Alyssa Bowling, BS – Johns Hopkins School of Medicine
Speaker: Wren Michaels, PhD (she/her/hers) – Chicago Medical School, Compound Screening and Drug Discovery Core
Speaker: Ofra Avizur Barchad, PhD – Splisense Ltd. Jerusalem, Israel
Speaker: Lucia Nicosia, MSc – University College Cork, Cork T12 K8AF, Ireland
Speaker: Uta Griesenbach – Imperial College London